Literature DB >> 19563775

Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth.

Jiying Wang1, Qing Rao, Min Wang, Hui Wei, Haiyan Xing, Hang Liu, Yanzhong Wang, Kejing Tang, Leiwen Peng, Zheng Tian, Jianxiang Wang.   

Abstract

Rac1 belongs to the Rho family that act as critical mediators of signaling pathways controlling cell migration and proliferation and contributes to the interactions of hematopoietic stem cells with their microenvironment. Alteration of Rac1 might result in unbalanced interactions and ultimately lead to leukemogenesis. In this study, we analyze the expression of Rac1 protein in leukemia patients and determine its role in the abnormal behaviours of leukemic cells. Rac1 protein is overexpressed in primary acute myeloid leukemia cells as compared to normal bone marrow mononuclear cells. siRNA-mediated silencing of Rac1 in leukemia cell lines induced inhibition of cell migration, proliferation, and colony formation. Additionally, blocking Rac1 activity by an inhibitor of Rac1-GTPase, NSC23766, suppressed cell migration and growth. We conclude that overexpression of Rac1 contributes to the accelerated migration and high proliferation potential of leukemia cells, which could be implicated in leukemia development and progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563775     DOI: 10.1016/j.bbrc.2009.06.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  RAC1P29S is a spontaneously activating cancer-associated GTPase.

Authors:  Matthew J Davis; Byung Hak Ha; Edna C Holman; Ruth Halaban; Joseph Schlessinger; Titus J Boggon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-02       Impact factor: 11.205

2.  Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.

Authors:  Massimiliano Cadamuro; Giorgia Nardo; Stefano Indraccolo; Luigi Dall'olmo; Luisa Sambado; Lidia Moserle; Irene Franceschet; Michele Colledan; Marco Massani; Tommaso Stecca; Nicolò Bassi; Stuart Morton; Carlo Spirli; Romina Fiorotto; Luca Fabris; Mario Strazzabosco
Journal:  Hepatology       Date:  2013-07-22       Impact factor: 17.425

3.  Activation of Rac1 GTPase promotes leukemia cell chemotherapy resistance, quiescence and niche interaction.

Authors:  Ji-Ying Wang; Pei Yu; Shuying Chen; Haiyan Xing; Yirui Chen; Min Wang; Kejing Tang; Zheng Tian; Qing Rao; Jianxiang Wang
Journal:  Mol Oncol       Date:  2013-05-15       Impact factor: 6.603

4.  LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuit.

Authors:  Yanling Tao; Jingjing Zhang; Lulu Chen; Xin Liu; Mingkang Yao; Hao Zhang
Journal:  Cell Death Dis       Date:  2021-05-18       Impact factor: 8.469

5.  Finding consistent disease subnetworks across microarray datasets.

Authors:  Donny Soh; Difeng Dong; Yike Guo; Limsoon Wong
Journal:  BMC Bioinformatics       Date:  2011-11-30       Impact factor: 3.169

6.  Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines.

Authors:  Natalia Fernández; Pablo Lorenzano Menna; Maia Cabrera; Emiliana Echeverria; Federico Remes Lenicov; Georgina Cardama; Nazareno Gonzalez; Carlos Davio
Journal:  Oncotarget       Date:  2017-10-04

7.  sFRP1 exerts effects on gastric cancer cells through GSK3β/Rac1‑mediated restraint of TGFβ/Smad3 signaling.

Authors:  Ji-Xiang Peng; Shun-Yu Liang; Li Li
Journal:  Oncol Rep       Date:  2018-10-31       Impact factor: 3.906

Review 8.  Rho GTPases modulate malignant transformation of tumor cells.

Authors:  Jose L Orgaz; Cecilia Herraiz; Victoria Sanz-Moreno
Journal:  Small GTPases       Date:  2014-05-08

9.  Role of SNTA1 in Rac1 activation, modulation of ROS generation, and migratory potential of human breast cancer cells.

Authors:  H F Bhat; R A Baba; M E Adams; F A Khanday
Journal:  Br J Cancer       Date:  2014-01-16       Impact factor: 7.640

10.  TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.

Authors:  Yihua Pang; Yanan Zhao; Yan Wang; Xinlu Wang; Ruiqing Wang; Na Liu; Peng Li; Min Ji; Jingjing Ye; Tao Sun; Jingxin Li; Daoxin Ma; Fei Lu; Chunyan Ji
Journal:  J Exp Clin Cancer Res       Date:  2020-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.